Table 1 Clinical and pathological characteristics of the recruited cohort
Variables | Total (n = 172) |
|---|---|
Age(year), M (Q₁, Q₃) | 71.00 (62.00, 75.25) |
Tumor size(cm), M (Q₁, Q₃) | 40.00 (30.00, 55.89) |
Surgery time(min), M (Q₁, Q₃) | 262.02 (234.50, 290.00) |
Sex, n(%) | |
Female | 70 (40.70) |
Male | 102 (59.30) |
BMI(kg/m2), n(%) | |
<18.5 | 31 (18.02) |
18.5–23.9 | 88 (51.16) |
≥ 24 | 53 (30.81) |
Pathology, n(%) | |
Squamous cell carcinoma | 126 (73.26) |
Adenocarcinoma | 32 (18.60) |
Other types | 14 (8.14) |
Diabetes, n(%) | |
No | 156 (90.70) |
Yes | 16 (9.30) |
Cardiovascular disease, n(%) | |
No | 149 (86.63) |
Yes | 23 (13.37) |
Tumor location, n(%) | |
Upper thoracic esophagus | 21 (12.21) |
Middle thoracic esophagus | 76 (44.19) |
Lower thoracic esophagus | 75 (43.60) |
Infection, n(%) | |
No | 134 (77.91) |
Yes | 38 (22.09) |
TNM stage, n(%) | |
I/II | 65 (37.79) |
III | 39 (22.67) |
IV | 68 (39.53) |
Surgical Method, n(%) | |
Minimally Invasive surgery | 57 (33.14) |
Open surgery | 115 (66.86) |
Anastomotic leakage, n(%) | |
No | 134 (77.91) |
Yes | 38 (22.09) |